PaRxVision Overview
- Year Founded
-
2020
- Status
-
Private
- Latest Deal Type
-
Accelerator/Inc
- Investors
-
2
PaRxVision General Information
Description
Operator of a biotech company intended to facilitate non-invasive ocular drug-delivery systems for retinal diseases, with a focus on eye-drop formulations. The company's technology uses para-transcription factors and targeted molecular pathways to improve treatment precision and reduce dependence on injectable therapies, providing healthcare professionals with a new approach for treating a variety of retinal diseases.
Contact Information
Website
www.parxvisions.comCorporate Office
- Plano, TX
- United States
Corporate Office
- Plano, TX
- United States
PaRxVision Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Accelerator/Incubator | Completed | Generating Revenue | ||||
| 1. Accelerator/Incubator | 09-Feb-2023 | Completed | Generating Revenue |
PaRxVision Investors (2)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| HSC Next | Accelerator/Incubator | |||
| TechFW | Accelerator/Incubator |
PaRxVision FAQs
-
When was PaRxVision founded?
PaRxVision was founded in 2020.
-
Where is PaRxVision headquartered?
PaRxVision is headquartered in Plano, TX.
-
What industry is PaRxVision in?
PaRxVision’s primary industry is Drug Discovery.
-
Is PaRxVision a private or public company?
PaRxVision is a Private company.
-
What is PaRxVision’s current revenue?
The current revenue for PaRxVision is .
-
Who are PaRxVision’s investors?
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process